Owkin raises €162.0M Series A round

This extension to the Series A round was raised to accelerate drug discovery and development and further expand the company's research network.

Source: https://techcrunch.com/2020/06/17/owkin-raises-another-18m-from-mubadala-and-bpifrance-to-expand-its-ai-for-medical-research/